Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AltiBio Logo
AltiBio Growth Score
78
CB Rank
557598
Heat Score
56
AltiBio is a biopharmaceutical firm that develops orphan therapeutics.
Founded
obfuscation
PrivateSeries A Half Moon Bay, California, United States1-10 www.altibio.bio/
Biopharma
Biotechnology
Pharmaceutical
Overview

AltiBio
Growth Score
78
Heat Score
56

Growth Score78
-8 pts
in past quarter
Heat Score 56
-16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About AltiBio

CB Rank
557598
AltiBio is a biopharmaceutical firm that develops orphan therapeutics.
Founded
obfuscation
PrivateSeries A Half Moon Bay, California, United States1-10 www.altibio.bio/
Biopharma
Biotechnology
Pharmaceutical

Funding Rounds

Series A
OBF
in
obfuscation

Details

Legal Name AltiBio, Inc.
Operating Status Active
Company Type For Profit
About the Company
AltiBio is a biopharmaceutical company that involves in developing and commercializing orphan therapeutics.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ATB226
A drug candidate developed for an undisclosed rare disease, currently in preclinical or early clinical development stages.
ATB227
A therapeutic candidate in development for an undisclosed rare disease, part of AltiBio's orphan drug portfolio.

Research & Development

AltiBio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - AltiBio Logo
Series A - AltiBio
—
obfuscation
— Series A
obfuscation
Series A - AltiBio Logo
Series A - AltiBio
—
obfuscation
— Series A
obfuscation
Series A - AltiBio Logo
Series A - AltiBio
—
obfuscation
— Series A
obfuscation
Series A - AltiBio Logo
Series A - AltiBio
—
obfuscation
— Series A
obfuscation
Series A - AltiBio Logo
Series A - AltiBio
—
obfuscation
— Series A

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - AltiBio Logo
Series A - AltiBio
—
obfuscation
— Series A
obfuscation
Series A - AltiBio Logo
Series A - AltiBio
—
obfuscation
— Series A
obfuscation
Series A - AltiBio Logo
Series A - AltiBio
—
obfuscation
— Series A
obfuscation
Series A - AltiBio Logo
Series A - AltiBio
—
obfuscation
— Series A
obfuscation
Series A - AltiBio Logo
Series A - AltiBio
—
obfuscation
— Series A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Board Members and Advisors 1 Contacts 3

Board Members and Advisors

News

News and Press

News•May 10, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 10, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$90.2KThis year, AltiBio is projected to spend $90.2K on IT, according to Aberdeen.

Active Website Tech Count

8AltiBio is actively using 8 technologies for its website, according to BuiltWith. These include Mobile Non Scaleable Content, CommonCrawl Top 100m, and  OpenResty.

Total IP

5The intellectual property of AltiBio includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, AltiBio has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is AltiBio's headquarters? AltiBio is located in Half Moon Bay, California, United States.When was the last funding round for AltiBio? AltiBio closed its last funding round on
obfuscation
from a Series A round.Who are AltiBio's competitors? Alternatives and possible competitors to AltiBio may include Vigil Neuroscience, Leal Therapeutics, and  Pretzel Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|